Patrick Donnelly
Stock Analyst at Citigroup
(5.00)
# 6
Out of 4,778 analysts
322
Total ratings
50.29%
Success rate
154.18%
Average return
Main Sectors:
Stocks Rated by Patrick Donnelly
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ILMN Illumina | Maintains: Neutral | $130 → $90 | $87.50 | +2.86% | 15 | Mar 4, 2025 | |
| TXG 10x Genomics | Maintains: Buy | $20 → $15 | $9.71 | +54.56% | 12 | Mar 4, 2025 | |
| AVTR Avantor | Maintains: Neutral | $22 → $18 | $16.35 | +10.13% | 8 | Mar 4, 2025 | |
| TECH Bio-Techne | Maintains: Neutral | $80 → $70 | $59.99 | +16.69% | 11 | Mar 4, 2025 | |
| HOLX Hologic | Maintains: Neutral | $80 → $70 | $60.78 | +15.17% | 14 | Mar 4, 2025 | |
| IQV IQVIA Holdings | Maintains: Neutral | $225 → $210 | $181.36 | +15.79% | 10 | Mar 4, 2025 | |
| MTD Mettler-Toledo International | Maintains: Neutral | $1,450 → $1,400 | $1,195.74 | +17.08% | 12 | Mar 4, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Neutral | $650 → $570 | $514.16 | +10.86% | 19 | Mar 4, 2025 | |
| DGX Quest Diagnostics | Downgrades: Neutral | $185 | $165.73 | +11.63% | 11 | Mar 4, 2025 | |
| CRL Charles River Laboratories International | Upgrades: Neutral | $155 → $175 | $161.38 | +8.44% | 20 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $285 → $265 | $212.48 | +24.72% | 12 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $300 → $290 | $179.01 | +62.00% | 8 | Jan 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $30 → $23 | $8.74 | +163.31% | 4 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $44 → $50 | $35.39 | +41.28% | 4 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $20 | $11.92 | +67.79% | 3 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $75 | $43.21 | +73.57% | 14 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $75 | $45.67 | +64.22% | 13 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $400 → $450 | $247.42 | +81.88% | 14 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $400 → $450 | $265.82 | +69.29% | 14 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $165 | $120.50 | +36.93% | 26 | Aug 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $45 | $46.49 | -3.20% | 9 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $28 | $21.13 | +32.51% | 4 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $135 → $145 | $107.41 | +35.00% | 1 | Jul 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $64 → $62 | $39.67 | +55.79% | 13 | Feb 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $265 → $300 | $368.63 | -18.62% | 24 | Dec 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $9 | $3.49 | +157.88% | 6 | Dec 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3.75 → $2.75 | $4.03 | -31.76% | 4 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $250 → $260 | $234.45 | +10.90% | 11 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $6 | $3.61 | +66.20% | 4 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $28 → $32 | $9.74 | +228.54% | 2 | Nov 30, 2018 |
Illumina
Mar 4, 2025
Maintains: Neutral
Price Target: $130 → $90
Current: $87.50
Upside: +2.86%
10x Genomics
Mar 4, 2025
Maintains: Buy
Price Target: $20 → $15
Current: $9.71
Upside: +54.56%
Avantor
Mar 4, 2025
Maintains: Neutral
Price Target: $22 → $18
Current: $16.35
Upside: +10.13%
Bio-Techne
Mar 4, 2025
Maintains: Neutral
Price Target: $80 → $70
Current: $59.99
Upside: +16.69%
Hologic
Mar 4, 2025
Maintains: Neutral
Price Target: $80 → $70
Current: $60.78
Upside: +15.17%
IQVIA Holdings
Mar 4, 2025
Maintains: Neutral
Price Target: $225 → $210
Current: $181.36
Upside: +15.79%
Mettler-Toledo International
Mar 4, 2025
Maintains: Neutral
Price Target: $1,450 → $1,400
Current: $1,195.74
Upside: +17.08%
Thermo Fisher Scientific
Mar 4, 2025
Maintains: Neutral
Price Target: $650 → $570
Current: $514.16
Upside: +10.86%
Quest Diagnostics
Mar 4, 2025
Downgrades: Neutral
Price Target: $185
Current: $165.73
Upside: +11.63%
Charles River Laboratories International
Mar 4, 2025
Upgrades: Neutral
Price Target: $155 → $175
Current: $161.38
Upside: +8.44%
Jan 30, 2025
Maintains: Buy
Price Target: $285 → $265
Current: $212.48
Upside: +24.72%
Jan 6, 2025
Maintains: Buy
Price Target: $300 → $290
Current: $179.01
Upside: +62.00%
Dec 11, 2024
Downgrades: Neutral
Price Target: $30 → $23
Current: $8.74
Upside: +163.31%
Dec 11, 2024
Upgrades: Buy
Price Target: $44 → $50
Current: $35.39
Upside: +41.28%
Nov 6, 2024
Maintains: Buy
Price Target: $18 → $20
Current: $11.92
Upside: +67.79%
Nov 6, 2024
Maintains: Buy
Price Target: $80 → $75
Current: $43.21
Upside: +73.57%
Nov 6, 2024
Maintains: Buy
Price Target: $80 → $75
Current: $45.67
Upside: +64.22%
Oct 31, 2024
Maintains: Buy
Price Target: $400 → $450
Current: $247.42
Upside: +81.88%
Oct 31, 2024
Maintains: Buy
Price Target: $400 → $450
Current: $265.82
Upside: +69.29%
Aug 22, 2024
Maintains: Buy
Price Target: $150 → $165
Current: $120.50
Upside: +36.93%
Aug 8, 2024
Maintains: Buy
Price Target: $40 → $45
Current: $46.49
Upside: -3.20%
Aug 7, 2024
Maintains: Buy
Price Target: $30 → $28
Current: $21.13
Upside: +32.51%
Jul 30, 2024
Maintains: Buy
Price Target: $135 → $145
Current: $107.41
Upside: +35.00%
Feb 8, 2024
Maintains: Buy
Price Target: $64 → $62
Current: $39.67
Upside: +55.79%
Dec 11, 2023
Maintains: Neutral
Price Target: $265 → $300
Current: $368.63
Upside: -18.62%
Dec 11, 2023
Maintains: Buy
Price Target: $7 → $9
Current: $3.49
Upside: +157.88%
Aug 10, 2023
Maintains: Neutral
Price Target: $3.75 → $2.75
Current: $4.03
Upside: -31.76%
Feb 17, 2023
Maintains: Neutral
Price Target: $250 → $260
Current: $234.45
Upside: +10.90%
Nov 3, 2022
Maintains: Buy
Price Target: $8 → $6
Current: $3.61
Upside: +66.20%
Nov 30, 2018
Upgrades: Neutral
Price Target: $28 → $32
Current: $9.74
Upside: +228.54%